JP2015511588A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511588A5 JP2015511588A5 JP2014561233A JP2014561233A JP2015511588A5 JP 2015511588 A5 JP2015511588 A5 JP 2015511588A5 JP 2014561233 A JP2014561233 A JP 2014561233A JP 2014561233 A JP2014561233 A JP 2014561233A JP 2015511588 A5 JP2015511588 A5 JP 2015511588A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- composition according
- tmp
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 21
- 201000010099 disease Diseases 0.000 claims 12
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 208000035475 disorder Diseases 0.000 claims 8
- 208000024891 symptom Diseases 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 7
- 239000012634 fragment Substances 0.000 claims 7
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 6
- 206010061218 Inflammation Diseases 0.000 claims 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 230000004054 inflammatory process Effects 0.000 claims 4
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 4
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims 3
- 208000011231 Crohn disease Diseases 0.000 claims 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 3
- 229940113720 aminosalicylate Drugs 0.000 claims 3
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- 230000003092 anti-cytokine Effects 0.000 claims 3
- 239000003246 corticosteroid Substances 0.000 claims 3
- 102000003675 cytokine receptors Human genes 0.000 claims 3
- 108010057085 cytokine receptors Proteins 0.000 claims 3
- 229960003444 immunosuppressant agent Drugs 0.000 claims 3
- 239000003018 immunosuppressive agent Substances 0.000 claims 3
- 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 claims 2
- 206010043561 Thrombocytopenic purpura Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 claims 2
- 230000036039 immunity Effects 0.000 claims 2
- 230000001861 immunosuppressant effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 208000026872 Addison Disease Diseases 0.000 claims 1
- 208000008190 Agammaglobulinemia Diseases 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 claims 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 claims 1
- 206010006458 Bronchitis chronic Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 201000000724 Chronic recurrent multifocal osteomyelitis Diseases 0.000 claims 1
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 208000016192 Demyelinating disease Diseases 0.000 claims 1
- 206010012305 Demyelination Diseases 0.000 claims 1
- 208000021866 Dressler syndrome Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 208000024869 Goodpasture syndrome Diseases 0.000 claims 1
- 208000003807 Graves Disease Diseases 0.000 claims 1
- 208000015023 Graves' disease Diseases 0.000 claims 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 claims 1
- 208000001204 Hashimoto Disease Diseases 0.000 claims 1
- 208000016905 Hashimoto encephalopathy Diseases 0.000 claims 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims 1
- 206010020983 Hypogammaglobulinaemia Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- 208000011200 Kawasaki disease Diseases 0.000 claims 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 claims 1
- 208000003926 Myelitis Diseases 0.000 claims 1
- 206010029260 Neuroblastoma Diseases 0.000 claims 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000033464 Reiter syndrome Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 206010047642 Vitiligo Diseases 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 208000007451 chronic bronchitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000023652 chronic gastritis Diseases 0.000 claims 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 208000010643 digestive system disease Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 206010028417 myasthenia gravis Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000002574 reactive arthritis Diseases 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012900999 | 2012-03-13 | ||
| AU2012900999A AU2012900999A0 (en) | 2012-03-13 | Method for treating inflammation | |
| PCT/AU2013/000247 WO2013134822A1 (en) | 2012-03-13 | 2013-03-13 | Method for treating inflammation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511588A JP2015511588A (ja) | 2015-04-20 |
| JP2015511588A5 true JP2015511588A5 (enExample) | 2016-05-12 |
| JP6144288B2 JP6144288B2 (ja) | 2017-06-07 |
Family
ID=49160149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561233A Active JP6144288B2 (ja) | 2012-03-13 | 2013-03-13 | 炎症を治療する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9637527B2 (enExample) |
| EP (1) | EP2849778B1 (enExample) |
| JP (1) | JP6144288B2 (enExample) |
| CN (1) | CN104411325B (enExample) |
| AU (1) | AU2013232733B2 (enExample) |
| CA (1) | CA2866819C (enExample) |
| ES (1) | ES2664237T3 (enExample) |
| NZ (1) | NZ629964A (enExample) |
| WO (1) | WO2013134822A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014324093A1 (en) * | 2013-09-18 | 2016-04-28 | James Cook University | Anti-inflammatory proteins and methods of use |
| CN105745223A (zh) | 2013-09-18 | 2016-07-06 | 詹姆斯库克大学 | 修饰的抗炎蛋白及使用方法 |
| EP3131559B1 (en) | 2014-04-16 | 2019-02-13 | Genovie AB | Cd8+ regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract |
| US10758568B2 (en) | 2014-04-16 | 2020-09-01 | Genovie Ab | Regulatory T-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract |
| CN105561030A (zh) * | 2015-09-18 | 2016-05-11 | 范月辉 | 一种治疗急性乳突炎的中药 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| US5284760A (en) | 1989-04-03 | 1994-02-08 | Feinstone Stephen M | Techniques for producing site-directed mutagenesis of cloned DNA |
| US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
| US5220007A (en) | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| WO1993013216A1 (en) | 1991-12-24 | 1993-07-08 | The President And Fellows Of Harvard College | Site-directed mutagenesis of dna |
| ATE207498T1 (de) | 1992-05-11 | 2001-11-15 | Corvas Int Inc | Neutrophilen inhibitoren aus nematoden |
| US5389514A (en) | 1992-08-28 | 1995-02-14 | Fox Chase Cancer Center | Method for specifically altering the nucleotide sequence of RNA |
| US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
| AUPM672594A0 (en) | 1994-07-08 | 1994-08-04 | Royal Children's Hospital Research Foundation | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| US5789166A (en) | 1995-12-08 | 1998-08-04 | Stratagene | Circular site-directed mutagenesis |
| WO1999047070A1 (en) | 1998-03-18 | 1999-09-23 | Wake Forest University | Improved implantable biomaterials, compositions and methods for their preparation and uses thereof |
| US7303752B2 (en) * | 2001-10-17 | 2007-12-04 | The George Washington University | Hookworm vaccine |
| US7928132B2 (en) * | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
| EP2350305A4 (en) * | 2008-10-22 | 2013-03-06 | Dyax Corp | COMBINATION TREATMENTS WITH PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISEASES |
-
2013
- 2013-03-13 JP JP2014561233A patent/JP6144288B2/ja active Active
- 2013-03-13 WO PCT/AU2013/000247 patent/WO2013134822A1/en not_active Ceased
- 2013-03-13 ES ES13761358.4T patent/ES2664237T3/es active Active
- 2013-03-13 CA CA2866819A patent/CA2866819C/en active Active
- 2013-03-13 AU AU2013232733A patent/AU2013232733B2/en active Active
- 2013-03-13 NZ NZ629964A patent/NZ629964A/en not_active IP Right Cessation
- 2013-03-13 US US14/384,681 patent/US9637527B2/en active Active
- 2013-03-13 EP EP13761358.4A patent/EP2849778B1/en active Active
- 2013-03-13 CN CN201380022472.0A patent/CN104411325B/zh active Active